Patents by Inventor Andres Acosta
Andres Acosta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250121033Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.Type: ApplicationFiled: December 23, 2024Publication date: April 17, 2025Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
-
Publication number: 20250099546Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: ApplicationFiled: September 4, 2024Publication date: March 27, 2025Applicant: University of Florida Research Foundation, IncorporatedInventors: Sergei Zolotukhin, Andres Acosta
-
Patent number: 12109251Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: GrantFiled: July 2, 2021Date of Patent: October 8, 2024Assignee: University of Florida Research Foundation, IncorporatedInventors: Sergei Zolotukhin, Andres Acosta
-
Patent number: 11911445Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.Type: GrantFiled: January 23, 2019Date of Patent: February 27, 2024Assignee: Gila Therapeutics, Inc.Inventors: Andres Acosta, Thomas Vasicek, Beth Anne-Szkudlarek Brown
-
Publication number: 20230084803Abstract: Compositions comprising satiety peptides (e.g., PYY, PYY(3-36), GLP-1, oxyntomodulin, and cholecystokinin) and DPP-IV inhibitors and methods of treating metabolic diseases with such compositions are provided.Type: ApplicationFiled: April 27, 2022Publication date: March 16, 2023Inventors: Andres ACOSTA, Thomas VASICEK
-
Publication number: 20220280658Abstract: The present application provides methods and compositions for AAV-mediated delivery of PYY and Glucagon-like Peptide 1 or an analog thereof (e.g., Exendin-4) to a subject (e.g., the saliva of a subject). In some embodiments, compositions and methods for topical delivery of Ex-4 and PYY peptides also are provided. Methods and compositions are useful to promote weight loss and/or altered lipid taste sensitivity, as well as for the treatment of diabetes.Type: ApplicationFiled: March 18, 2022Publication date: September 8, 2022Applicant: University of Florida Research Foundation, IncorporatedInventors: Sergei Zolotukhin, Sean M. Crosson, Cedrick Shawn Dotson, Seth Currlin, Andres Acosta
-
Publication number: 20220143146Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.Type: ApplicationFiled: June 1, 2021Publication date: May 12, 2022Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
-
Patent number: 11311633Abstract: The present application provides methods and compositions for AAV-mediated delivery of PYY and Glucagon-like Peptide 1 or an analog thereof (e.g., Exendin-4) to a subject (e.g., the saliva of a subject). In some embodiments, compositions and methods for topical delivery of Ex-4 and PYY peptides also are provided. Methods and compositions are useful to promote weight loss and/or altered lipid taste sensitivity, as well as for the treatment of diabetes.Type: GrantFiled: April 17, 2017Date of Patent: April 26, 2022Assignee: University of Florida Research Foundation, IncorporatedInventors: Sergei Zolotukhin, Sean M. Crosson, Cedrick Shawn Dotson, Seth Currlin, Andres Acosta
-
Publication number: 20210401942Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: ApplicationFiled: July 2, 2021Publication date: December 30, 2021Applicant: University of Florida Research Foundation, IncorporatedInventors: Sergei Zolotukhin, Andres Acosta
-
Publication number: 20210308223Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.Type: ApplicationFiled: June 1, 2021Publication date: October 7, 2021Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
-
Patent number: 11103556Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: GrantFiled: September 5, 2019Date of Patent: August 31, 2021Assignee: University of Florida Research Foundation, IncorporatedInventors: Sergei Zolotukhin, Andres Acosta
-
Publication number: 20200061158Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: ApplicationFiled: September 5, 2019Publication date: February 27, 2020Applicant: University of Florida Research Foundation, Inc.Inventors: Sergei Zolotukhin, Andres Acosta
-
Publication number: 20190231850Abstract: Pharmaceutical compositions comprising PYY (e.g., PYY(3-36) and analogs and variants thereof), satiety peptides, satiety hormones, metabolic hormones, and methods of treating metabolic diseases with such compositions are provided. Aspects include methods of increasing a feeling of fullness in patients treated with pharmaceutical compositions comprising PYY, PYY(3-36), satiety peptides, satiety hormones, metabolic hormones, and analogs, receptor antagonists and variants thereof.Type: ApplicationFiled: January 23, 2019Publication date: August 1, 2019Inventors: Andres ACOSTA, Thomas VASICEK, Beth Anne-Szkudlarek BROWN
-
Publication number: 20190224280Abstract: Compositions comprising satiety peptides (e.g., PYY, PYY(3-36), GLP-1, oxyntomodulin, and cholecystokinin) and DPP-IV inhibitors and methods of treating metabolic diseases with such compositions are provided.Type: ApplicationFiled: January 9, 2019Publication date: July 25, 2019Inventors: Andres ACOSTA, Thomas VASICEK
-
Publication number: 20190119165Abstract: The invention describes a process for obtaining clay having improved characteristics that comprises incorporating an inorganic matrix onto an organic matrix at determined proportions. The industrial clay obtained is malleable and highly resistant to compression and strain, of great use in the industry of prototype elaboration.Type: ApplicationFiled: April 27, 2017Publication date: April 25, 2019Inventors: Luis Fernando Sierra Zuluaga, Diego Andres Acosta Maya, Julian Jaramillo Vallejo, Andres Restrepo Montoya, Alexaner Ramillo Rodriguez, Jose Luis Cadavid Cardenas
-
Publication number: 20170080056Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: ApplicationFiled: September 21, 2016Publication date: March 23, 2017Applicant: University of Florida Research Foundation, Inc.Inventors: Sergei Zolotukhin, Andres Acosta
-
Patent number: 9492505Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: GrantFiled: January 21, 2010Date of Patent: November 15, 2016Assignee: University of Florida Research Foundation, Inc.Inventors: Sergei Zolotukhin, Andres Acosta
-
Publication number: 20120035100Abstract: Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.Type: ApplicationFiled: January 21, 2010Publication date: February 9, 2012Inventors: Sergei Zolotukhin, Andres Acosta
